Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01229826 · ClinicalTrials.gov registry record
Magnetic Resonance Elastography (MRE) of Uterine Fibroids
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 134
- Enrollment target
NCT01229826: Completed study, sponsored by Mayo Clinic.
NCT01229826 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 134 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01229826 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 134 participants
- Enrollment target
Study Summary
The purpose of this study is to gain additional information regarding use of Magnetic Resonance Elastography (MRE) for uterine fibroid characterization. In this study, the investigators will use a new noninvasive technology, MRE, to further characterize the elastic properties of the uterine fibroids. To date, very little is known concerning how the tissue composition of the uterine fibroid may affect its treatment with Magnetic Resonance Guided Focused Ultrasound (MRgFUS). In this study, the investigators will use a new noninvasive technology, magnetic resonance elastography (MRE), to further characterize the elastic properties of the uterine fibroids. This information will be gathered during routine magnetic resonance imaging for symptomatic uterine fibroids. It is known that some fibroids with increased T2-signal on Magnetic Resonance Imaging(MRI) can be more difficult to treat. This information will be gathered during routine magnetic resonance imaging for symptomatic uterine fibroids.
Interventions
- RADIATION MR Elastography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2010-10 |
| Est. Completion | 2015-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01229826
The ClinicalTrials.gov registry entry for NCT01229826 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MR Elastography is the first listed.
NCT01229826 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01229826 about?
NCT01229826 is a clinical study titled "Magnetic Resonance Elastography (MRE) of Uterine Fibroids". The purpose of this study is to gain additional information regarding use of Magnetic Resonance Elastography (MRE) for uterine fibroid characterization. In this study, the investigators will use a new noninvasive technology, MRE, to further characterize the elastic properties of the uterine fibroids...
What is the current status of trial NCT01229826?
This trial is currently completed. The enrollment target is 134 participants. The study started on 2010-10. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01229826?
The interventions under investigation include: MR Elastography (RADIATION).
Who is sponsoring clinical trial NCT01229826?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.